Loading...

PerCP/Cyanine5.5 anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_PerCPCyanine55_CD45_Antibody_082418
C57BL/6 mouse splenocytes were stained with CD45 (Clone 30-F11) PerCP/Cyanine5.5 (filled histogram), or rat IgG2b, κ PerCP/Cyanine5.5 isotype control (open histogram).
  • 30-F11_PerCPCyanine55_CD45_Antibody_082418
    C57BL/6 mouse splenocytes were stained with CD45 (Clone 30-F11) PerCP/Cyanine5.5 (filled histogram), or rat IgG2b, κ PerCP/Cyanine5.5 isotype control (open histogram).
Compare all formats See PerCP/Cyanine5.5 spectral data
Cat # Size Price Quantity Check Availability Save
103131 25 µg 70€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103132 100 µg 177€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  2. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
  3. Daemen S, et al. 2021. Cell Reports. 34(2):108626. PubMed
  4. Zaman R, et al. 2021. Immunity. :. PubMed
  5. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  6. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  7. Xuan W, et al. 2022. Cancer Immunol Res. 10:770. PubMed
  8. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  9. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  10. Wu X, et al. 2022. J Clin Med. 11: . PubMed
  11. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  12. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  13. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  14. Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed
  15. Lai C, et al. 2023. J Bone Miner Res. 38:86. PubMed
  16. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  17. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  18. Zha AH, et al. 2022. Lupus Sci Med. 9: . PubMed
  19. Guo J, et al. 2023. Cell Rep Med. 4:100881. PubMed
  20. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  21. Liu G, et al. 2023. Commun Biol. 6:102. PubMed
  22. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  23. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  24. Khan NZ, et al. 2021. Brain Behav Immun. 92:165. PubMed
  25. Na E, et al. 2022. Am J Physiol Lung Cell Mol Physiol. 322:L550. PubMed
  26. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  27. Li X, et al. 2022. Cell. 185:1709. PubMed
  28. Zhang Q, et al. 2022. Nat Metab. 4:1055. PubMed
  29. Bermea KC, et al. 2022. J Vis Exp. . PubMed
  30. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  31. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  32. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  33. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  34. Fei F, et al. 2022. Int J Mol Sci. 23:. PubMed
  35. Shi H, et al. 2022. Nutrients. 14:. PubMed
  36. Li J, et al. 2022. Elife. 11:. PubMed
  37. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  38. Xiao Y, et al. 2023. EMBO J. 42:e111762. PubMed
  39. He Y, et al. 2023. Biomolecules. 13:. PubMed
  40. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  41. Doloff JC, et al. 2023. Sci Adv. 9:eade9488. PubMed
  42. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  43. Jung IY, et al. 2022. Sci Transl Med. 14:eabn7336. PubMed
  44. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  45. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  46. Xiong W, et al. 2022. Nat Commun. 13:1700. PubMed
  47. Tadic, S., Garc 2025. Int J Mol Sci. 26(21),0. PubMed
  48. Li Z, et al. 2021. Immunology. 163:105. PubMed
  49. Krausgruber T, et al. 2020. Nature. 583:296. PubMed
  50. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  51. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  52. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  53. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  54. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  55. Padonou F, et al. 2022. EMBO Rep. 23:e53576. PubMed
  56. Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed
  57. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  58. Li Y, et al. 2022. Int J Biol Sci. 18:3697. PubMed
  59. Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed
  60. Browning D, et al. 2017. Gene Ther. 10.1038/gt.2016.88. PubMed
  61. Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed
  62. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  63. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  64. Yang M, et al. 2020. Cell Prolif. 53:e12784. PubMed
  65. Rodda LB et al. 2018. Immunity. 48(5):1014-1028 . PubMed
  66. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  67. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  68. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  69. Garcia–Agudo LF, et al. 2019. FASEB J. :fj201900337R. PubMed
  70. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  71. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  72. Biffi G, et al. 2018. Cancer Discov. 2:282. PubMed
  73. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  74. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  75. Craver BM, et al. 2020. Blood Adv. 4:312. PubMed
  76. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
  77. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  78. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  79. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  80. Damal Villivalam S, et al. 2020. Nat Commun. 4313:11. PubMed
  81. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  82. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  83. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  84. Shen H, et al. 2022. Nat Commun. 13:6030. PubMed
  85. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  86. Potluri HK, et al. 2022. J Immunother Cancer. 10:. PubMed
  87. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  88. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  89. Fernandez Garcia-Agudo L, et al. 2021. Cell Rep. 36:109548. PubMed
  90. Chung H, et al. 2021. Immune Netw. 21:e28. PubMed
  91. Wang C, et al. 2021. Cell Stem Cell. . PubMed
  92. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  93. Sakaguchi M, et al. 2022. Nat Commun. 13:6092. PubMed
  94. Chimenti I, et al. 2022. Cell Death Discov. 8:149. PubMed
  95. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  96. Osborne JK, et al. 2021. Cell Reports. 36(3):109408. PubMed
  97. Wei SC, et al. 2020. Cancer Discov. . PubMed
  98. Voisin M, et al. 2021. Commun Biol. 4:420. PubMed
  99. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  100. Fleury M, et al. 2015. Development. 142: 3307 - 3320. PubMed
  101. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  102. Alexander RK, et al. 2020. eLife. 9:e54090.. PubMed
  103. Vasilijevic J, et al. 2017. PLoS Pathog. 13:e1006650. PubMed
  104. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  105. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  106. Peres-Emidio EC, et al. 2022. Front Cell Infect Microbiol. 12:811474. PubMed
  107. Cong M, et al. 2021. Methods Mol Biol. 2388:59. PubMed
  108. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  109. Nicholas DA, et al. 2020. Scientific Reports. 10(1):13063. PubMed
  110. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  111. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  112. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  113. Lee J, et al. 2022. Nat Commun. 13:1516. PubMed
  114. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  115. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  116. Li N, et al. 2021. eLife. 10:00. PubMed
  117. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  118. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  119. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  120. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  121. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  122. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  123. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  124. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  125. Hu Y, et al. 2021. Bioact Mater. 2905:6. PubMed
  126. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  127. Hsu CY, et al. 2020. Frontiers in Immunology. 11:574839. PubMed
  128. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  129. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  130. Adrover JM et al. 2019. Immunity. 50(2):390-402 . PubMed
  131. Christ A, et al. 2018. Cell. 172:162. PubMed
  132. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  133. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  134. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  135. Yang Z, et al. 2021. Sci Adv. 7:. PubMed
  136. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  137. Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed
  138. Wang Y, et al. 2020. Cell Death Dis. 1.169444444. PubMed
  139. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  140. Shao M, et al. 2021. Cell Stem Cell. 28(4):685-701.e7. PubMed
  141. Liu Z, et al. 2015. Development. 142: 2452 - 2463. PubMed
  142. Branchett WJ, et al. 2020. Wellcome Open Research. 0.278472222. PubMed
  143. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  144. Du Q et al. 2019. Dev Cell. 49(4):618-631 . PubMed
  145. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  146. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  147. Mittal A, et al. 2021. Sci Rep. 11:10731. PubMed
  148. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  149. Weinstock A, et al. 2021. Elife. :10. PubMed
  150. Joffin N, et al. 2021. Cell Stem Cell. 28(4):702-717.e8. PubMed
  151. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  152. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  153. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  154. Sun L, et al. 2015. Sci Rep. 5: 14871. PubMed
  155. Timblin GA, et al. 2021. Nat Metab. 3:618. PubMed
  156. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  157. Lang V, et al. 2021. Elife. 10:. PubMed
  158. Toth K, et al. 2022. PLoS Biol. 20:e3001526. PubMed
  159. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  160. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  161. Chandra J, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.83. PubMed
  162. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  163. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  164. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  165. Li CJ, et al. 2018. J Clin Invest. 128:5251. PubMed
  166. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  167. Tuong ZK, et al. 2021. iScience. 24:103326. PubMed
  168. Thomas K, et al. 2022. JCI Insight. :. PubMed
  169. Xu X, et al. 2022. EMBO Rep. 23:e53509. PubMed
  170. Pizzurro GA, et al. 2021. Cancers (Basel). 13:. PubMed
  171. Olson B, et al. 2021. Brain Behav Immun. 97:102. PubMed
  172. Calle P, et al. 2021. Cells. 10:. PubMed
  173. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  174. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  175. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  176. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  177. Ngamsri KC, et al. 2020. Front Immunol. 11:407. PubMed
  178. Haider N, et al. 2020. Cell Commun Signal. 18:26. PubMed
  179. Bernstock JD, et al. 2019. J Allergy Clin Immunol. 145:358. PubMed
  180. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  181. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  182. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  183. Dong X, et al. 2022. Front Immunol. 13:896472. PubMed
  184. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  185. Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed
  186. Ko HJ, et al. 2020. Front Immunol. 1897:11. PubMed
  187. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
  188. Casanova-Acebes M, et al. 2018. J Exp Med. 215:2778. PubMed
  189. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  190. Scott NA, et al. 2018. Front Immunol. 2.319444444. PubMed
  191. Klose A, et al. 2018. JCSM Rapid Commun. 9:20222. PubMed
  192. Karolin A, et al. 2022. Front Pharmacol. 12:789080. PubMed
  193. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  194. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  195. Steele NG, et al. 2021. Clin Cancer Res. 27:2023. PubMed
  196. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  197. Mesnieres M, et al. 2021. Cell Reports. 36(8):109618. PubMed
  198. Doss PMIA, et al. 2021. Cell Reports. 34(10):108833. PubMed
  199. Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed
  200. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  201. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  202. Böhm AM et al. 2019. Dev Cell. 51(2):236-254 . PubMed
  203. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  204. Mello AM, et al. 2022. Oncogenesis. 11:56. PubMed
  205. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  206. Sánchez-del-Campo L, et al. 2021. J Exp Clin Cancer Res. 40:117. PubMed
  207. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  208. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  209. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  210. Chung S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. L921:318. PubMed
  211. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  212. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  213. Patel K, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.11. PubMed
  214. Miragaia RJ, et al. 2018. Sci Rep. 8:685. PubMed
  215. Baron CS, et al. 2018. Nat Commun. 9:2517. PubMed
  216. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  217. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  218. Yu H, et al. 2021. Cell Death Dis. 13:1. PubMed
  219. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  220. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  221. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  222. Liu SS, et al. 2021. Immunity. :. PubMed
  223. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  224. Gao P, et al. 2020. Front Immunol. 1.636111111. PubMed
  225. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  226. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  227. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  228. Schulze J, et al. 2021. Stroke. 52:2939. PubMed
  229. Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed
  230. Garcia-Alegria E, et al. 2016. Sci Rep. 6: 25917. PubMed
  231. Wang L, et al. 2020. Nat Commun. 0.654166667. PubMed
  232. Durga Devi T, et al. 2017. Am J Pathol. 187:2659. PubMed
  233. Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed
  234. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  235. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  236. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  237. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  238. Sheriff L, et al. 2020. Dis Model Mech. 13:dmm046383. PubMed
  239. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
  240. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  241. Omori S, et al. 2020. Cell Metabolism. 32(5):814-828.e6. PubMed
  242. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  243. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  244. Mitchell LA, et al. 2019. Oncotarget. 10:2252. PubMed
  245. Han Y, et al. 2019. J Clin Invest. 130:26. PubMed
  246. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  247. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  248. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  249. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  250. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
RRID
AB_893344 (BioLegend Cat. No. 103131)
AB_893340 (BioLegend Cat. No. 103132)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

How stable is PerCP/Cyanine5.5 tandem as compared to PerCP alone?

PerCP/Cyanine5.5 is quite photostable and also better than PerCP alone in withstanding fixation.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC
StarBright UltraViolet 740 anti-mouse CD45 30-F11 FC
PE/Fire™ 744 anti-mouse CD45 30-F11 FC
StarBright UltraViolet 665 anti-mouse CD45 30-F11 FC
Go To Top Version: 3    Revision Date: 08/24/2018

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account